C07K 16/121
Helicobacter
Official title: Helicobacter (G); Campylobacter (G)
C07K16/121 (Helicobacter) appears on 77 US grants and 99 published applications in this corpus.
Search patents in C07K- Granted patents
- 77
- Published applications
- 99
- Assignees
- 62
- Inventors
- 203
- Latest grant
- 24 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 3 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 4 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 2 |
| 2002 | 5 | 11 |
| 2003 | 2 | 7 |
| 2004 | 6 | 4 |
| 2005 | 1 | 7 |
| 2006 | 2 | 2 |
| 2007 | 1 | 2 |
| 2008 | 1 | 3 |
| 2009 | 2 | 3 |
| 2010 | 1 | 2 |
| 2011 | 1 | 2 |
| 2012 | 1 | 6 |
| 2013 | 2 | 5 |
| 2014 | 3 | 2 |
| 2015 | 5 | 6 |
| 2016 | 4 | 2 |
| 2017 | 4 | 7 |
| 2018 | 5 | 3 |
| 2019 | 2 | 2 |
| 2020 | 4 | 5 |
| 2021 | 1 | 5 |
| 2022 | 2 | 2 |
| 2023 | 2 | 1 |
| 2024 | 0 | 1 |
| 2025 | 2 | 4 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Agents and methods for the prevention or treatment of H. pylori infections24 Feb 2026US 12,558,425 B2Max-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V.
- Arthrospira platensis non-parenteral therapeutic delivery platform23 Dec 2025US 12,503,682 B2Lumen Bioscience, Inc.
- Antibodies against Campylobacter species13 May 2025US 12,297,258 B2Humabs Biomed SA
- Helicobacter therapeutic21 Nov 2023US 11,819,546 B2Murdoch Childrens Research Institute
- Methods of treating viral infections by administering an antibody preparation comprising IGG, IGA and IGM10 Oct 2023US 11,780,909 B2Biotest AG
- Anti-microbial antibody signatures related to lung tumors and uses thereof9 Jul 2026US 2026/0194524 A1Arizona Board of Regents on behalf of Arizona State University
- Arthrospira platensis non-parenteral therapeutic delivery platform23 Apr 2026US 2026/0109941 A1Lumen Bioscience, Inc.
- Methods for preventing the development of a gastric disease associated with helicobacter pylori infection without eradicating the infection and for the assessment of the risk of developing such disease2 Apr 2026US 2026/0091099 A1
- Vaccine against campylobacter jejuni27 Nov 2025US 2025/0360193 A1
- IgY Antibody Compositions and Methods for Treating Avian Species25 Sep 2025US 2025/0295770 A1Mammal Labs Inc.
Most cited
By later US patents
- Immuno-chromatographic rapid assay in order to detect acid-resistant microorganisms in the stool100US 7,129,053 B1DakoCytomation Denmark A/S · 2006
- Oral treatment of helicobacter infection35US 5,538,729 AOraVax, Inc. · 1996
- Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides30US 5,843,460 AInstitut National de la Sante et de la Recherche Medicale · 1998
- System and method for the production of recombinant glycosylated proteins in a prokaryotic host27US 8,703,471 B2ETH Zurich · 2014
- Method and product for the treatment of gastric disease23US 5,260,057 AAbbott Laboratories · 1993